Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Alaunos Therapeutics, Inc.
| Metric | Alaunos Therapeutics, Inc. TCRTHealthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $5,000 |
| Net income (latest) | −$4M |
| Operating margin | −84500.0% |
| Net margin | −83520.0% |
| Return on equity | −194.0% |
| Return on assets | −140.8% |
| Return on capital (ROCE) | −196.2% |
| Debt / equity | 0.38× |
| Revenue growth (YoY) | −50.0% |
| Altman Z″ (distress) | -1020.47 |
| Accruals / assets | −44.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.